Bessemer Group’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Hold |
937
| – | – | ﹤0.01% | 1742 |
|
|
2025
Q1 | $12K | Hold |
937
| – | – | ﹤0.01% | 1701 |
|
|
2024
Q4 | $12K | Hold |
937
| – | – | ﹤0.01% | 1692 |
|
|
2024
Q3 | $14K | Hold |
937
| – | – | ﹤0.01% | 1580 |
|
|
2024
Q2 | $13K | Hold |
937
| – | – | ﹤0.01% | 1456 |
|
|
2024
Q1 | $13K | Sell |
937
-450
| -32% | -$6.24K | ﹤0.01% | 1504 |
|
|
2023
Q4 | $19K | Sell |
1,387
-238
| -15% | -$3.26K | ﹤0.01% | 1479 |
|
|
2023
Q3 | $21K | Buy |
1,625
+688
| +73% | +$8.89K | ﹤0.01% | 1473 |
|
|
2023
Q2 | $13K | Hold |
937
| – | – | ﹤0.01% | 1601 |
|
|
2023
Q1 | $13K | Sell |
937
-143
| -13% | -$1.98K | ﹤0.01% | 1445 |
|
|
2022
Q4 | $15K | Sell |
1,080
-6,650
| -86% | -$92.4K | ﹤0.01% | 1369 |
|
|
2022
Q3 | $106K | Hold |
7,730
| – | – | ﹤0.01% | 1014 |
|
|
2022
Q2 | $110K | Hold |
7,730
| – | – | ﹤0.01% | 1001 |
|
|
2022
Q1 | $128K | Hold |
7,730
| – | – | ﹤0.01% | 928 |
|
|
2021
Q4 | $149K | Hold |
7,730
| – | – | ﹤0.01% | 915 |
|
|
2021
Q3 | $161K | Hold |
7,730
| – | – | ﹤0.01% | 833 |
|
|
2021
Q2 | $166K | Hold |
7,730
| – | – | ﹤0.01% | 834 |
|
|
2021
Q1 | $152K | Buy |
7,730
+937
| +14% | +$18.4K | ﹤0.01% | 800 |
|
|
2020
Q4 | $134K | Hold |
6,793
| – | – | ﹤0.01% | 809 |
|
|
2020
Q3 | $119K | Hold |
6,793
| – | – | ﹤0.01% | 820 |
|
|
2020
Q2 | $122K | Hold |
6,793
| – | – | ﹤0.01% | 1214 |
|
|
2020
Q1 | $102K | Hold |
6,793
| – | – | ﹤0.01% | 1118 |
|
|
2019
Q4 | $118K | Sell |
6,793
-36
| -0.5% | -$625 | ﹤0.01% | 1159 |
|
|
2019
Q3 | $103K | Buy |
6,829
+304
| +5% | +$4.59K | ﹤0.01% | 1171 |
|
|
2019
Q2 | $110K | Hold |
6,525
| – | – | ﹤0.01% | 1193 |
|
|
2019
Q1 | $112K | Sell |
6,525
-7,649
| -54% | -$131K | ﹤0.01% | 1115 |
|
|
2018
Q4 | $214K | Buy |
+14,174
| New | +$214K | ﹤0.01% | 960 |
|